Ceragenix gets FDA device designation
This article was originally published in Clinica
Executive Summary
The US FDA has told Ceragenix Pharmaceuticals that it would regulate as a device the firm's antimicrobial wound dressing for preventing infection at the site of indwelling medical device insertions into the body.